Rundu Co., Ltd. announced that in January 2025, the company previously submitted a marketing application for the marketing of chemical raw materials produced in the domestic production of levodipine benzenesulfonate, and completed additional research and submitted information in March 2026. In August 2026, the company obtained the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” issued by the State Drug Administration, and this product was approved for registration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.